NOT KNOWN FACTS ABOUT SUVOREXANT

Avoid coadministration with sensitive CYP3A substrates. If coadministration unavoidable, observe for adverse reactions and minimize CYP3A substrate dose in accordance with product or service labeling.Check Closely (1)ribociclib will enhance the degree or outcome of triazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism.Consistently keep